Even though we confirmed BRCA1 binding to RRM2 promoter in NHA and BJ cells, BRCA1 loss was not associated with reduction in RRM2 protein levels in these cells (Supplementary Fig. 1d), thereby indicating that this regulatory mechanism is unique to GBM cells. The gene discussed is BRCA1; the disease is glioblastoma.